Panel Discussion: How Can We Invigorate AKI Drug Development? Identifying Novel Targets & Establishing a Pathway to Surmount Challenges in Biomarkers & Precision Medicine

Time: 2:15 pm
day: Seminar Day


  • What can we learn from clinical setbacks in AKI?
  • Addressing translational barriers in AKI: optimizing models to predict efficacy and biomarkers of therapeutic target engagement
  • Characterizing endophenotypes through omics approaches to enable comprehensive, longitudinal understanding of AKI